ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.990,31
0,44%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03989
1,18%
Bitcoin
106.661,00
3,38%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Deutschland
  5. TG

  6. Novonesis AS (NZM2) Börsenkurse

Novonesis AS

Novonesis AS (NZM2)

TG
55,02
0,32
( 0,59% )
Aktualisiert: 17:57:09
Echtzeitdaten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
55,02
Gebot
55,00
Fragen
55,24
Volumen
1.669
54,56 Tagesbereich 55,02
46,68 52-Wochen-Bereich 65,16
Marktkapitalisierung
22,809B
Handelsende
54,70
Handelsbeginn
54,86
Letzte Trade
100
@
55.02
Letzter Handelszeitpunkt
17:33:52
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.517
Ausgegebene Aktien
414.555.046
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
7,50
Gewinn pro Aktie (EPS)
7,29
Erlöse
17,9B
Nettogewinn
3,02B

Über Novonesis AS

Sektor
Pharmaceutical Preparations
Branche
Medicinal Chems,botanicl Pds
Website
www.novonesis.com
Hauptsitz
Kongens Lyngby, Dnk
Gegründet
1999
Novonesis AS is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker NZM2. The last closing price for Novonesis AS was 54,70 €. Over the last year, Novonesis AS shares have traded in a share price range of 46,68 € to 65,16 €.

Novonesis AS currently has 414.555.046 shares in issue. The market capitalisation of Novonesis AS is 22,68 € billion. Novonesis AS has a price to earnings ratio (PE ratio) of 7.50.

NZM2 Neueste Nachrichten

Weitere Nachrichten

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission...

03 Januar 2025
UK Regulatory

Change to Novonesis’ Board of Directors

Change to Novonesis’ Board of Directors Sharon James will not be seeking re-election to the Board of Directors of Novonesis at the upcoming annual general meeting in 2025 and will step down...

17 Dezember 2024
UK Regulatory

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to...

29 November 2024
UK Regulatory

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to...

27 November 2024
UK Regulatory

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to...

25 November 2024
UK Regulatory

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission...

20 November 2024
UK Regulatory

Novonesis will host an educational conference call on Energy on December 18

Novonesis will host an educational conference call on Energy on December 18 Novonesis will host a spotlight educational session on our Energy activities which is part of Planetary Health...

18 November 2024
UK Regulatory

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to...

13 November 2024
UK Regulatory

Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%

Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8% Following increasing demand in the first nine months of the 2024 financial...

07 November 2024
UK Regulatory

Trading statement 9M 2024

Trading statement 9M 2024 Organic pro forma sales growth of 9%, including 11% in the third quarter. Full-year organic sales growth outlook now expected at the upper end of the 7-8% range and the...

07 November 2024
UK Regulatory
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
11.182.1916790490353.8455.0252.52183253.45575672DE
40.821.5129151291554.255.5252.52136854.12704094DE
12-4.3-7.2488199595459.326051.62151755.142117DE
26-1.4-2.4813895781656.4265.1651.62159158.06448904DE
527.5815.978077571747.4465.1646.68218255.65698436DE
156-8.7-13.653483992563.726736.01172952.20450102DE
260-16.08-22.616033755371.172.6236.01162852.32881987DE

NZM2 - Frequently Asked Questions (FAQ)

What is the current Novonesis AS share price?
The current share price of Novonesis AS is 55,02 €
How many Novonesis AS shares are in issue?
Novonesis AS has 414.555.046 shares in issue
What is the market cap of Novonesis AS?
The market capitalisation of Novonesis AS is EUR 22,68B
What is the 1 year trading range for Novonesis AS share price?
Novonesis AS has traded in the range of 46,68 € to 65,16 € during the past year
What is the PE ratio of Novonesis AS?
The price to earnings ratio of Novonesis AS is 7,5
What is the cash to sales ratio of Novonesis AS?
The cash to sales ratio of Novonesis AS is 1,27
What is the reporting currency for Novonesis AS?
Novonesis AS reports financial results in DKK
What is the latest annual turnover for Novonesis AS?
The latest annual turnover of Novonesis AS is DKK 17,9B
What is the latest annual profit for Novonesis AS?
The latest annual profit of Novonesis AS is DKK 3,02B
What is the registered address of Novonesis AS?
The registered address for Novonesis AS is BIOLOGIENS VEJ 2, KONGENS LYNGBY, 2800
What is the Novonesis AS website address?
The website address for Novonesis AS is www.novonesis.com
Which industry sector does Novonesis AS operate in?
Novonesis AS operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
E3O1Nexoptic Technology Corp
0,023 €
(48,39%)
2,22k
MBQMobotix AG
0,505 €
(41,85%)
5,76k
GRFGreiffenberger AG
0,79 €
(35,04%)
52,52k
UH7ATennant Minerals NL
0,0085 €
(30,77%)
102,91k
PF8European Lithium Limited
0,0486 €
(27,89%)
3,8M
VOPInvestigator Resources Ltd
0,011 €
(-38,89%)
1,69k
D4GDataMetrex AI Ltd
0,0036 €
(-33,33%)
4k
KQ9Nine Mile Metals Ltd
0,008 €
(-33,33%)
171,13k
3D7Willow Biosciences Inc
0,035 €
(-32,69%)
50k
W4VAlphaGen Intelligence Corp
0,0095 €
(-32,14%)
1,56k
D7GNel ASA
0,1987 €
(3,17%)
4,73M
PF8European Lithium Limited
0,0486 €
(27,89%)
3,8M
HDDHeidelberger Druckmaschinen AG
1,052 €
(8,01%)
2M
QJ4Auric Minerals Corp
0,66 €
(3,13%)
1,78M
LHADeutsche Lufthansa AG
5,91 €
(1,20%)
1,22M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TG
NZM2
Novonesis AS
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten